Efficacy of High-Dose Mycophenolate Mofetil in Multitarget Therapy for Lupus Nephritis: Two Consecutive Case Reports

Cureus
doi 10.7759/cureus.6834
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Cureus, Inc.

Related search

Cyclophosphamide Versus Mycophenolate Mofetil for Initial Treatment of Lupus Nephritis

Kidney International
Nephrology
2013English

Mycophenolate Mofetil for Induction Therapy of Lupus Nephritis: A Systematic Review and Meta-Analysis

Clinical Journal of the American Society of Nephrology
EpidemiologyNephrologyCritical CareTransplantationIntensive Care Medicine
2007English

81 Outcomes of Multi-Target Therapy Using Mycophenolate Mofetil and Tacrolimus for Refractory Lupus Nephritis

2017English

Comparative Effectiveness of Mycophenolate Mofetil for the Treatment of Childhood-Onset Proliferative Lupus Nephritis

Arthritis Care and Research
Rheumatology
2017English

Outcomes Following Mycophenolate Mofetil Versus Cyclophosphamide Induction Treatment for Proliferative Juvenile-Onset Lupus Nephritis

Lupus
Rheumatology
2019English

Mycophenolate Mofetil or Intravenous Cyclophosphamide for Lupus Nephritis With Poor Kidney Function: A Subgroup Analysis of the Aspreva Lupus Management Study

American Journal of Kidney Diseases
Nephrology
2013English

Mycophenolate Mofetil Reduces STAT3 Phosphorylation in Systemic Lupus Erythematosus Patients

JCI insight
Medicine
2019English

Pharmacokinetics of Enteric Coated Mycophenolate Sodium in Lupus Nephritis (POEMSLUN)

Therapeutic Drug Monitoring
Pharmacology
2019English

Editorial: Tailoring Mycophenolate Mofetil Rescue Therapy for Success in Autoimmune Hepatitis

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy